BioSpace News Archive

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that it had signed an advance purchase agreement with Gavi, the Vaccine Alliance, which is on behalf of COVAX Facility, to provide up to 380 million doses of inactivated COVID-19 vaccine, CoronaVac®for distribution through the COVAX Facility.

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced its clinical trial with leronlimab in combination with carboplatin for the treatment of metastatic triple-negative breast cancer has advanced from Phase 1b to a Phase 2 trial.

Vizient, Inc. announced today member registration is open for the 2021 Vizient Innovative Technology Exchange.

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced that it will host a virtual R&D Day at 4:00 pm ET.

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that Andy Schmidt has been appointed Chief Financial Officer effective immediately.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful innovations to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced enrollment of the first patient in its single pivotal Phase 3 clinical trial evaluating topical roflumilast foam (ARQ-154) as a potential treatment for seborrheic dermatitis

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced the appointment of Matthew Ruth as Chief Commercial Officer.

PolyPid Ltd., a late-stage biopharma company focusing on developing targeted, locally administered and prolonged-release therapeutics to improve surgical outcomes, announced that it has appointed leading colorectal surgeon Anthony J. Senagore, M.D., as its Senior Medical Director.

InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the second quarter of 2021 before the Nasdaq market opens on Wednesday, July 28, 2021.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO ®.